We are one of the few practices in the North Texas
area to prescribe

The U.S. Food and Drug Administration (FDA) has approved LATISSE™ (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes.

________________________________________________________

LATISSE™ is the first and only science based treatment approved by the FDA to enhance eyelash prominence as measured by increased length, thickness and darkness of the eyelashes.

972-423-3937 

Dr Agustin Gonzalez, OD. FAAO

Dr Clarissa De Paz, OD

Dr Luis Robles, MD

www.EyeAndVision.net